Transforming TAVI practice: Evidence, equity, and durability
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Join this session if you want to:
Discussion topic | Speakers |
---|---|
SMART Trial results - a landmark head-to-head randomized controlled TAVI trial |
D. Tchétché (FR) |
Addressing underdiagnosis in women with aortic stenosis |
J. Grapsa (GB) |
Durability in TAVI valves: Data, predictors and real-world insights |
J. J. Wykrzykowska (NL) |